News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication May 14, 2019 Identifying Outcomes in Clinical Trials of Fistulizing Crohn’s Disease for the Development of a Core Outcome Set Read Now
Publication May 14, 2019 Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease Read Now
Publication May 14, 2019 Definitions of response and remission for the Robarts Histopathology Index Read Now
Publication May 14, 2019 Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials Read Now
Publication May 14, 2019 Early combined immunosuppression may be effective and safe in older patients with Crohn’s disease: post hoc analysis of REACT Read Now
Publication May 14, 2019 Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative Colitis Read Now
